Core Insights - The main business of Guobang Pharmaceutical includes research, production, and sales of products related to pharmaceuticals and animal health products. The pharmaceutical segment accounts for the highest revenue share at 64.87%, followed by the animal health segment at 34.24% [2] Financial Performance - In 2021, Guobang Pharmaceutical achieved a net profit attributable to shareholders of 706 million yuan, which increased to 782 million yuan by 2024, reflecting a cumulative growth of 10.70% over the years. The company has not reported any losses in the past four years [2] - From a revenue perspective, Guobang Pharmaceutical's revenue grew from 4.505 billion yuan in 2021 to 5.891 billion yuan in 2024, indicating an overall upward trend despite some fluctuations during the period [2] - The net profit attributable to shareholders increased from 706 million yuan in 2021 to 782 million yuan in 2024, showing steady improvement amidst fluctuations [2] Market Valuation - Since its listing, Guobang Pharmaceutical's market value has declined. The peak market value reached 26.768 billion yuan on August 3, 2021, with a stock price of 47.9 yuan. As of the close on August 1, the stock price was 23.5 yuan, and the market value was 13.132 billion yuan, representing a decrease of 13.635 billion yuan, or 50.94% from its peak [5]

Core Insights - Lingxiao Pump Industry has experienced significant growth since its listing on July 11, 2017, with a market value increase from 3.248 billion to 5.716 billion yuan, despite fluctuations in revenue and profit in recent years [1][3] Business Overview - The main business of Lingxiao Pump Industry includes the research, design, production, and sales of civil centrifugal pumps, with core products being plastic bathroom pumps (46.64% of revenue) and stainless steel pumps (35.09% of revenue) [3] - The company achieved a net profit attributable to shareholders of 188 million yuan in 2017, growing to 442 million yuan by the end of the latest complete fiscal year in 2024, marking a cumulative profit growth of 134.87% [3] Financial Performance - Revenue showed a fluctuating trend, with 1.435 billion yuan in 2020 and 1.592 billion yuan in 2024, indicating a rise, fall, and subsequent recovery [3] - The net profit attributable to shareholders also experienced fluctuations, increasing from 359 million yuan in 2020 to 442 million yuan in 2024, reflecting an overall upward trajectory [3] Market Valuation - The peak market value of Lingxiao Pump Industry reached 10.099 billion yuan on December 23, 2021, with a stock price of 28.4 yuan, but as of July 10, the market value decreased to 5.716 billion yuan, representing a reduction of 4.383 billion yuan or 43.40% [5]

Core Viewpoint - Wanma Co., Ltd. has experienced significant growth since its listing in 2009, with a market capitalization increase from 5.186 billion to 14.2 billion, although its profitability has shown fluctuations in recent years [1][3]. Business Overview - The main business segments of Wanma Co., Ltd. include electric wires and cables, new materials, and new energy, with electric power products accounting for the largest revenue share at 66.14%, followed by high polymer materials at 29.20% [3]. - Since its listing, the company has achieved a cumulative profit growth of 292.44%, with a net profit of 0.87 million in 2009 and 3.41 million in the latest fiscal year of 2024 [3]. Financial Performance - Wanma Co., Ltd. has maintained profitability, with 12 out of 16 years showing net profit growth, representing 75% of the years since its listing [3]. - The company’s revenue has grown significantly, from 9.322 billion in 2020 to 17.761 billion in 2024, reflecting a compound annual growth rate of 17.46% over the past five years [3]. - Despite a decline in net profit from 2.23 million in 2020 to 3.41 million in 2024, the overall profitability remains stable [3]. Market Capitalization - Since its listing, Wanma Co., Ltd. has seen its market capitalization grow by 1.74 times, peaking at 42.565 billion in June 2015, with a stock price of 45.3 yuan [5]. - As of July 9, the stock price was 14.0 yuan, resulting in a market capitalization of 14.2 billion, which is a decrease of 28.365 billion or 66.64% from its peak [5].